RPL18P1

Across TCGA patient cohorts, RPL18P1 RNA expression is significantly associated with the go_rna of many other GO terms, with 2,900 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RPL18P1-associated GO terms across cancer lineages are Pyridine-containing compound metabolic process, Lipid oxidation, and Organic hydroxy compound biosynthetic process. Each is linked with RPL18P1 in more than 5 cancer types. Because this analysis shows association rather than direction, both RPL18P1-to-partner and partner-to-RPL18P1 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Pyridine-containing compound metabolic process grouped by RPL18P1-low versus RPL18P1-high in ESCA.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL18P1→partner) and Y-score (partner→RPL18P1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
ESCA	Pyridine-containing compound metabolic process →	+0.071	+0.022	<.001	.004	2	6
ESCA	Lipid oxidation →	+0.084	+0.020	<.001	.007	1	6
ESCA	Organic hydroxy compound biosynthetic process →	+0.059	+0.032	<.001	.002	2	5
KIRC	C-terminal protein lipidation →	+0.035	+0.007	<.001	.001	3	4
STAD	Iron-sulfur cluster assembly →	+0.061	+0.032	<.001	.003	3	3
BRCA	Peptidyl-lysine dimethylation →	+0.057	+0.010	<.001	.004	2	4

Each partner links to its Q-omics profile. Showing the 6 strongest of 2,900 associations by consensus.

Pyridine-containing compound metabolic process by RPL18P1 expression — ESCA

Explore this box plot interactively →